{"id":44911,"date":"2026-04-06T14:41:22","date_gmt":"2026-04-06T14:41:22","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/44911\/"},"modified":"2026-04-06T14:41:22","modified_gmt":"2026-04-06T14:41:22","slug":"roche-holding-ltd-rhhby-stock-forecasts","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/44911\/","title":{"rendered":"Roche Holding Ltd (RHHBY) Stock Forecasts"},"content":{"rendered":"\n<p data-testid=\"typography\" class=\" type-body-md-bold    yf-gjjls9\">Summary <\/p>\n<p data-testid=\"typography\" class=\" type-body-sm-reg    yf-gjjls9\">Roche Holding AG operates through two segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment focuses on oncology, immunology, ophthalmology, infectious diseases and neuroscience, and the Diagnostics segment specializes in in vitro diagnostics. Headquartered in Basel, Switzerland, the company was founded by Fritz Hoffmann-La Roche in 1896.  <\/p>\n<p data-testid=\"typography\" class=\" type-body-sm-reg    yf-gjjls9\">The company has approximately 103,249 full-time employees.  <\/p>\n<p data-testid=\"typography\" class=\" type-body-sm-reg    yf-gjjls9\">Roche has substantial market shares in oncology treatments and in vitro diagnostics and is working to combine its experti  <\/p>\n","protected":false},"excerpt":{"rendered":"Summary Roche Holding AG operates through two segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment focuses on oncology, immunology,&hellip;\n","protected":false},"author":2,"featured_media":44694,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[159,114,166,39,167,160,161,168,162,163,169,170,171,172,173,174,134,175,164,165,176,177,178,179],"class_list":["post-44911","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-401k","tag-business","tag-business-news","tag-economy","tag-finance","tag-financial-information","tag-investing","tag-investment-tools","tag-investor","tag-market-news","tag-mortgage","tag-mutual-funds","tag-personal-finance","tag-quote","tag-real-estate","tag-retirement","tag-roche","tag-stock","tag-stock-research","tag-stock-valuation","tag-stocks","tag-suze-orman","tag-tax","tag-track-portfolio"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116358288861735783","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/44911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=44911"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/44911\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/44694"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=44911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=44911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=44911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}